Company Filing History:
Years Active: 2015
Title: Hirohisa Kobayashi: Innovator in Pharmaceutical Formulations
Introduction
Hirohisa Kobayashi is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of stable tablets. His work has led to advancements that benefit patients requiring specific medication delivery systems.
Latest Patents
Kobayashi holds a patent for a stable tablet containing droxidopa. This innovative tablet comprises droxidopa as an active ingredient in a proportion of 20-80 wt % relative to the total weight of the tablet. The formulation is characterized by the inclusion of at least one excipient selected from mannitol, lactose, erythritol, glucose, sucrose, crystalline cellulose, and corn-derived starch. Additionally, the patent describes a preparation that utilizes corn-derived processed starch or polyvinyl alcohol as a binder, ensuring the stability of the tablet containing droxidopa.
Career Highlights
Kobayashi is associated with Sumitomo Dainippon Pharma Co., Ltd., where he has been instrumental in developing innovative pharmaceutical products. His expertise in tablet formulation has positioned him as a key figure in the company’s research and development efforts.
Collaborations
Throughout his career, Kobayashi has collaborated with esteemed colleagues such as Yasushi Ochiai and Teruko Ariyama. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical sector.
Conclusion
Hirohisa Kobayashi's contributions to pharmaceutical formulations, particularly through his patent on stable tablets containing droxidopa, highlight his role as an influential inventor in the industry. His work continues to impact the development of effective medication delivery systems.